Press Releases

• Cyxone receive regulatory approval to start clinical Phase 2b study in RA

  19 Sep, 2022 08:30 CEST

• Cyxone appoints Erika Samuelsson as Chief Development Officer

  2 Sep, 2022 11:01 CEST

• Ola Skanung new CFO at Cyxone, replacing Henrik Hang

  31 Aug, 2022 15:00 CEST
  Regulatory

• Interim Report 1 January to 30 June 2022

  24 Aug, 2022 08:30 CEST
  Regulatory

• Cyxone files submission to start clinical Phase 2b study in Poland and Georgia

  14 Jul, 2022 11:11 CEST